ReviewSmall science2025
Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections.
Review in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- An All-in-One Au@CeOAdvanced healthcare materials · 2026Article
- Bacterial secondary metabolites as resistance-modifying adjuvants: microbial origins, molecular mechanisms, and translational relevance.Frontiers in microbiology · 2026Review
- Incorporation of Edible Plant Extracts as Natural Food Preservatives: Green Extraction Methods, Antibacterial Mechanisms and Applications.Foods (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infections caused by pathogenic bacteria pose a significant threat to human health. Fluorescent antibiotics present an innovative material class that combines diagnostic capabilities with therapeutic effects. Fluorescent antibiotics offer a transformative strategy by combining precise visualization of bacterial activity with targeted antimicrobial action, addressing key challenges like drug resistance and rapid pathogen detection in diagnostics and treatment. This review highlights recent advances in the development of fluorescent antibiotics, focusing on chemical strategies such as click chemistry, amide bond formation, solid-phase peptide synthesis, and epoxy-amine addition. Also, the practical applications of these fluorescent probes, ranging from imaging, rapid detection, and real-time visual tracking of pathogenic bacteria to the detailed study of molecular dynamics at the cellular level are discussed. The opportunity to combine detection and treatment of infectious diseases underscores the significant promise of these probes, particularly in the face of escalating antimicrobial resistance. However, despite the promise, most studies are confined to laboratory settings. To move forward, continued innovation and rigorous clinical validation will be essential to translating these promising molecular tools from laboratory research to impactful clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.